Literature DB >> 4758363

Letter: Malignant hyperthermia in the dog.

C E Short, R R Paddleford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4758363     DOI： 10.1097/00000542-197310000-00033

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

Review 1.  Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

2.  Postanesthetic myonecrosis in horses.

Authors:  S C Friend
Journal:  Can Vet J       Date:  1981-12       Impact factor: 1.008

3.  Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis.

Authors:  P J O'Brien; G W Forsyth; D W Olexson; H S Thatte; P B Addis
Journal:  Can J Comp Med       Date:  1984-10

4.  Erythrocyte osmotic fragility testing and the prediction of canine malignant hyperthermia susceptibility.

Authors:  P H Cribb; E A Olfert; F B Reynolds
Journal:  Can Vet J       Date:  1986-12       Impact factor: 1.008

5.  Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony.

Authors:  P J O'brien; P H Cribb; R J White; E D Olfert; J E Steiss
Journal:  Can Vet J       Date:  1983-06       Impact factor: 1.008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.